Akhtari J - Search Results

1

No association between the risk of breast cancer and systemic lupus erythematosus: evidence from a meta-analysis.

Rezaieyazdi Z, Tabaei S, Ravanshad Y, Akhtari J, Mehrad-Majd H. Rezaieyazdi Z, et al. Among authors: akhtari j. Clin Rheumatol. 2018 Jun;37(6):1511-1519. doi: 10.1007/s10067-017-3950-9. Epub 2018 Jan 2. Clin Rheumatol. 2018. PMID: 29294194

2

Effects of Gly71Arg mutation in UGT1A1 gene on neonatal hyperbilirubinemia: a systematic review and meta-analysis.

Mehrad-Majd H, Haerian MS, Akhtari J, Ravanshad Y, Azarfar A, Mamouri G. Mehrad-Majd H, et al. Among authors: akhtari j. J Matern Fetal Neonatal Med. 2019 May;32(10):1575-1585. doi: 10.1080/14767058.2017.1410789. Epub 2017 Dec 10. J Matern Fetal Neonatal Med. 2019. PMID: 29179591

3

In vitro antitumor activity of patulin on cervical and colorectal cancer cell lines.

Abastabar M, Akbari A, Akhtari J, Hedayati MT, Shokohi T, Mehrad-Majd H, Ghalehnoei H, Ghasemi S. Abastabar M, et al. Among authors: akhtari j. Curr Med Mycol. 2017 Mar;3(1):25-29. doi: 10.18869/acadpub.cmm.3.1.25. Curr Med Mycol. 2017. PMID: 29302627 Free PMC article.

4

Nanovehicle-based Small Interfering RNA (siRNA) Delivery for Therapeutic Purposes: A New Molecular Approach in Pharmacogenomics.

Akhtari J, Tafazoli A, Mehrad-Majd H, Mahrooz A. Akhtari J, et al. Curr Clin Pharmacol. 2018;13(3):173-182. doi: 10.2174/1574884713666180709152610. Curr Clin Pharmacol. 2018. PMID: 29992895 Review.

5

Clinicopathological and prognostic value of lncRNA PANDAR expression in solid tumors: Evidence from a systematic review and meta-analysis.

Mehrad-Majd H, Akhtari J, Haerian MS, Ravanshad Y. Mehrad-Majd H, et al. Among authors: akhtari j. J Cell Physiol. 2019 Apr;234(4):4206-4216. doi: 10.1002/jcp.27179. Epub 2018 Sep 7. J Cell Physiol. 2019. PMID: 30191982

6

Decreased expression of lncRNA loc285194 as an independent prognostic marker in cancer: A systematic review and meta-analysis.

Mehrad-Majd H, Ravanshad S, Moradi A, Khansalar N, Sheikhi M, Akhtari J. Mehrad-Majd H, et al. Among authors: akhtari j. Pathol Res Pract. 2019 Jun;215(6):152426. doi: 10.1016/j.prp.2019.04.018. Epub 2019 Apr 28. Pathol Res Pract. 2019. PMID: 31054796

7

Wnt-β-catenin Signaling Pathway, the Achilles' Heels of Cancer Multidrug Resistance.

Ghandadi M, Valadan R, Mohammadi H, Akhtari J, Khodashenas S, Ashari S. Ghandadi M, et al. Among authors: akhtari j. Curr Pharm Des. 2019;25(39):4192-4207. doi: 10.2174/1381612825666191112142943. Curr Pharm Des. 2019. PMID: 31721699 Review.

8

Evaluation of anticancer effect of colchicum autumnale L. Corm on breast cancer cell.

Falahianshafiei S, Akhtari J, Davoodi A, Pasha H. Falahianshafiei S, et al. Among authors: akhtari j. BMC Complement Med Ther. 2023 Oct 7;23(1):357. doi: 10.1186/s12906-023-04189-0. BMC Complement Med Ther. 2023. PMID: 37805533 Free PMC article.

9

Improved therapeutic activity of HER2 Affibody-targeted cisplatin liposomes in HER2-expressing breast tumor models.

Alavizadeh SH, Akhtari J, Badiee A, Golmohammadzadeh S, Jaafari MR. Alavizadeh SH, et al. Among authors: akhtari j. Expert Opin Drug Deliv. 2016;13(3):325-36. doi: 10.1517/17425247.2016.1121987. Epub 2015 Dec 16. Expert Opin Drug Deliv. 2016. PMID: 26578208

10

Targeting, bio distributive and tumor growth inhibiting characterization of anti-HER2 affibody coupling to liposomal doxorubicin using BALB/c mice bearing TUBO tumors.

Akhtari J, Rezayat SM, Teymouri M, Alavizadeh SH, Gheybi F, Badiee A, Jaafari MR. Akhtari J, et al. Int J Pharm. 2016 May 30;505(1-2):89-95. doi: 10.1016/j.ijpharm.2016.03.060. Epub 2016 Mar 30. Int J Pharm. 2016. PMID: 27039149

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52 results

Search Page

Filters